These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38216834)

  • 1. Acute and definitive management of oropharyngeal hemorrhage in patients with squamous cell carcinoma of the oropharynx.
    Araujo AV; Wax MK; Clayburgh DR; Andersen PE; Chandra RA; Li RJ
    Head Neck; 2024 Apr; 46(4):896-904. PubMed ID: 38216834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of neck dissection in N2-3 oropharyngeal squamous cell carcinomas treated with definitive chemoradiotherapy: An observational real-life study].
    Klausner G; Troussier I; Kreps S; Fabiano E; Laccourreye O; Giraud P
    Cancer Radiother; 2021 Dec; 25(8):771-778. PubMed ID: 34175226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catastrophic Hemorrhage After Chemoradiation for Advanced Stage Oropharyngeal Carcinoma: A Case Series.
    Chou CT; Rath TJ; Johnson JT; Goyal LK
    Laryngoscope; 2021 May; 131(5):1049-1052. PubMed ID: 33068291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of postradiation late hemorrhage following treatment for HPV-positive oropharyngeal squamous cell carcinoma.
    Stevens MN; Gallant JN; Feldman MJ; Sermarini AJ; Cmelak A; Murphy B; Langerman A; Kim Y; Rohde SL; Mannion K; Sinard RJ; Netterville JL; Chitale R; Topf MC
    Head Neck; 2022 May; 44(5):1079-1085. PubMed ID: 35150023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major haemorrhage after non-surgical management of oropharyngeal squamous cell carcinoma.
    Leedman S; Thompson A; Phillips T; Sader C
    J Laryngol Otol; 2023 Jun; 137(6):667-672. PubMed ID: 35979640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
    Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute arterial hemorrhage following radiotherapy of oropharyngeal squamous cell carcinoma.
    Greve J; Bas M; Schuler P; Turowski B; Scheckenbach K; Budach W; Bölke E; Bergmann C; Lang S; Arweiler-Harbeck D; Lehnerdt G; Mattheis S; Bier H; Hoffmann TK
    Strahlenther Onkol; 2010 May; 186(5):269-73. PubMed ID: 20437014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prophylactic gastrostomy or reactive NG tube upon patient-reported long term swallow function following chemoradiotherapy for oropharyngeal carcinoma: A matched pair analysis.
    Sethugavalar B; Teo MT; Buchan C; Ermiş E; Williams GF; Sen M; Prestwich RJD
    Oral Oncol; 2016 Aug; 59():80-85. PubMed ID: 27424186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multistep and Multidisciplinary Management for Post-irradiated Carotid Blowout Syndrome in a Young Patient With Oropharyngeal Carcinoma: A Case Report.
    Sallustro M; Abualhin M; Faggioli G; Pilato A; Dall'Olio D; Simonetti L; Astarita F; Amorosa L; Gargiulo M
    Ann Vasc Surg; 2020 Aug; 67():565.e1-565.e5. PubMed ID: 32209410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hemorrhage after chemoradiation for oropharyngeal squamous cell carcinoma.
    Self EM; Bumpous J; Ziegler C; Wilson L; Potts K
    JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):356-61. PubMed ID: 23599070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swallowing outcomes for patients with oropharyngeal squamous cell carcinoma treated with primary (chemo)radiation therapy receiving either prophylactic gastrostomy or reactive nasogastric tube: A prospective cohort study.
    Goff D; Coward S; Fitzgerald A; Paleri V; Moor JW; Patterson JM
    Clin Otolaryngol; 2017 Dec; 42(6):1135-1140. PubMed ID: 28128886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
    Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term outcomes of oropharyngeal cancer care in the elderly.
    Motz K; Herbert RJ; Fakhry C; Quon H; Kang H; Kiess AP; Eisele DW; Koch WM; Frick KD; Gourin CG
    Laryngoscope; 2018 Sep; 128(9):2084-2093. PubMed ID: 29573418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. It is not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy.
    Naik M; Ward MC; Bledsoe TJ; Kumar AM; Rybicki LA; Saxton JP; Burkey BB; Greskovich JF; Adelstein DJ; Koyfman SA
    Oral Oncol; 2015 Aug; 51(8):800-4. PubMed ID: 25977228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving outcomes in veterans with oropharyngeal squamous cell carcinoma through implementation of a multidisciplinary clinic.
    Light T; Rassi EE; Maggiore RJ; Holland J; Reed J; Suriano K; Stooksbury M; Tobin N; Gross N; Clayburgh D
    Head Neck; 2017 Jun; 39(6):1106-1112. PubMed ID: 28370667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Primary Treatment Modality for Advanced-Stage Oropharyngeal Squamous Cell Carcinoma With Survival Outcomes.
    Tsai MH; Cheng YJ; Pao TH; Hsueh WT; Chen HHW; Wu YH
    JAMA Netw Open; 2021 Jun; 4(6):e2112067. PubMed ID: 34061201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
    Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D
    Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
    Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.